Washington Trust Advisors, Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Washington Trust Advisors, Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,703
+10.6%
2580.0%0.00%0.0%
Q2 2023$10,586
-55.1%
258
-60.9%
0.00%
-50.0%
Q1 2023$23,589
-5.4%
6600.0%0.00%
-33.3%
Q4 2022$24,928
-62.8%
660
-56.7%
0.00%
-50.0%
Q3 2022$67,000
+9.8%
1,525
-6.8%
0.01%
+20.0%
Q2 2022$61,000
-18.7%
1,637
-19.4%
0.01%0.0%
Q1 2022$75,000
+1.4%
2,031
-16.4%
0.01%0.0%
Q4 2021$74,0002,4300.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders